Journal
TISSUE ENGINEERING PART B-REVIEWS
Volume 27, Issue 4, Pages 353-365Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ten.teb.2020.0188
Keywords
tissue engineering; spinal cord injury; nanotechnology; biomaterials
Categories
Funding
- Ministerio de Ciencia, Tecnologia, Informacao e Comunicacoes
- Conselho Nacional de Pesquisa (CNPq) grant [404745/2012-1, 465656/2014-5]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)
- Stem Cell Research Institute
- CNPq/postdoc senior scholarship [167408/2013-5]
Ask authors/readers for more resources
Spinal cord injury is a severe condition with no current rehabilitation treatment available. Progress in nanotechnology and tissue engineering for SCI treatment has shown promise, but application in humans is still in the theoretical stage.
Spinal cord injury (SCI) affects the central nervous system (CNS) and there is currently no treatment with the potential for rehabilitation. Although several clinical treatments have been developed, they are still at an early stage and have not shown success in repairing the broken fiber, which prevents cellular regeneration and integral restoration of motor and sensory functions. Considering the importance of nanotechnology and tissue engineering for neural tissue injuries, this review focuses on the latest advances in nanotechnology for SCI treatment and tissue repair. The PubMed database was used for the bibliographic survey. Initial research using the following keywords tissue engineering and spinal cord injury revealed 970 articles published in the last 10 years. The articles were further analyzed, excluding those not related to SCI or with results that did not pertain to the field of interest, including the reviews. It was observed that a total of 811 original articles used the quoted keywords. When the word treatment was added, 662 articles were found and among them, 529 were original ones. Finally, when the keywords Nanotechnology and spinal cord injury were used, 102 articles were found, 65 being original articles. A search concerning the biomaterials used for SCI found 700 articles with 589 original articles. A total of 107 articles were included in the discussion of this review and some are used for the theoretical framework. Recent progress in nanotechnology and tissue engineering has shown promise for repairing CNS damage. A variety of in vivo animal testing for SCI has been used with or without cells and some of these in vivo studies have shown successful results. However, there is no translation to humans using nanotechnology for SCI treatment, although there is one ongoing trial that employs a tissue engineering approach, among other technologies. The first human surgical scaffold implantation will elucidate the possibility of this use for further clinical trials. This review concludes that even though tissue engineering and nanotechnology are being investigated as a possibility for SCI treatment, tests with humans are still in the theoretical stage. Impact statement Thousands of people are affected by spinal cord injury (SCI) per year in the world. This type of lesion is one of the most severe conditions that can affect humans and usually causes permanent loss of strength, sensitivity, and motor function below the injury site. This article reviews studies on the PubMed database, assessing the publications on SCI in the study field of tissue engineering, focusing on the use of nanotechnology for the treatment of SCI. The review makes an evaluation of the biomaterials used for the treatment of this condition and the techniques applied for the production of nanostructured biomaterials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available